Portfolio News

Phase 3 Data Supporting Rayaldee As a Treatment for Secondary Hyperparathyroidism in Chronic Kidney Disease to be Presented at ENDO 2015 Conference

March 6, 2015

MIAMI--(BUSINESS WIRE)-- OPKO Health, Inc. (NYSE: OPK), today announced the presentation of late-breaking clinical data in a poster at the 97th Annual Meeting of the Endocrine Society (ENDO) on March 6th, 2015 in San Diego, California, that will include twelve months data from OPKO's phase 3 trials for Rayaldee™ as a treatment for secondary hyperparathyroidism (SHPT) in patients with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency. The data to be presented include results for 429 patients completing up to twelve months of treatment.

Turk Telekom Enables Service Orchestration Using Nakina Systems

March 4, 2015

OTTAWA, Ontario--()--Nakina announced today that Turk Telekom, the leading national operator providing fixed and mobile voice, video and data services to consumer and commercial customers throughout Turkey, is

Telcel Selects Nakina Network Integrity Solutions

February 11, 2015

OTTAWA, Ontario--(BUSINESS WIRE)--Nakina announced today that Telcel, a leading mobile network operator in Mexico and part of 

Nakina Joins the Intel® Network Builders Program

January 29, 2015

OTTAWA, Ontario--()--Nakina announced today it is joining in the Intel® Network Builders program-- a program designed to accelerate deployment of software-defined networking (SDN) and network function virtu

$40-million project takes plant beyond ethanol production

January 28, 2015

Expansion plans at GreenField Specialty Alcohols Inc. in Chatham are taking shape.The company announced $40-million worth of investments in capital projects at the plant on Bloomfield Road in October.Angelo Ligori, plant manger, gave an update on the plans during a presentation at the Chatham-Kent Farm Show Wednesday.“Most people still think we’re a fuel (ethanol) plant,” said Ligori of the company’s future plans. “That’s ‘old-school.’ We’ve moved on.